DeutschNewstral
Article
Iinvezz.com on 2022-08-04 18:10
Eli Lilly Q2 results: its Alzheimer’s drug could be ‘the biggest drug in history’
Related news
- FEli Lilly chief seeks to recover from Alzheimer’s drug flopft.com
- MEli Lilly CEO on slicing tips, potential weight problems drug, Alzheimer’s trialmvtelegraph.com
- FPharmaceuticals: Alzheimer’s drug failure deals blow to US drugmaker Eli Lillyft.com
- FEli Lilly raises Alzheimer’s drug hopesft.com
- IEli Lilly stock price forecast ahead of obesity drug approvalinvezz.com
Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer’s Drug Trialswsj.com
Eli Lilly applies for FDA approval on Alzheimer’s drugnwaonline.com
Dementia: Eli Lilly drug shown to slow Alzheimer’s progressionFinancial Times- Eli Lilly & Co: Eli Lilly to seek US approval after Alzheimer’s drug trial successFinancial Times
Eli Lilly ends drug development, stock plungesUSA today- FEli Lilly & Co: US regulator delays decision on Eli Lilly’s Alzheimer’s drugft.com
- FHigh stakes: Eli Lilly’s hunt for an Alzheimer’s drugft.com
- FEli Lilly drops as Humalog drug sales disappointft.com
Eli Lilly to seek FDA approval for Alzheimer’s drug that firm says slows cognitive declineAlaska Dispatch News- FDA delays action on promising Alzheimer’s drug donanemab, drugmaker Eli Lilly saysUSA today
- IEli Lilly CEO explains why profit missed estimates in fiscal Q2invezz.com
- FAstraZeneca and Eli Lilly scrap Alzheimer’s trialft.com
- MPfizer enters weight reduction drug market with Novo Nordisk, Eli Lillymvtelegraph.com
- MNew pain drug from Pfizer and Eli Lilly shows promise as opioid alternativemarketwatch.com